Search

everythinglearnresearchcommunity

for

Search:↓

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Minoxidil can help grow hair and make hair follicles bigger, but it can also cause side effects.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Lupus can look like hair loss from alopecia areata but needs different treatment.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

A woman had a skin condition with increased normal elastic fibers, not related to other known disorders, likely due to aging.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Personalized treatment plans are important for people with alopecia areata.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Dupilumab for skin problems might reactivate hair loss in some patients.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.